Jason J. Preator
NEW YORK—Kavanagh Consulting LLC, a leading advisory and consultancy services firm in the vision care industry with existing offices in New York and Scottsdale, Ariz., has named Jason J. Preator as managing partner and head of its newly created Dallas office. Preator joins Kavanagh Consulting with 20 years of progressive financial and business development experience. Most recently, he held several executive leadership positions at Essilor of America, including his role as a member of its executive committee as well as overseeing its finance, sourcing and procurement, and merger and acquisitions functions. “I am really excited to join Kavanagh Consulting and work with Anne Kavanagh and team in helping business owners and doctors maximize the value and business potential of their practices and companies,” Preator said.
Kavanagh Consulting founder and CEO, Anne Kavanagh, noted, “Tom Hull, our Scottsdale office partner, and I are very excited to have Jason join us. Jason is a financial and M&A expert with extensive knowledge of and relationships in the vision care sector. His addition enables Kavanagh Consulting the ability to immediately expand our business into being the dominant advisor for lab acquisitions, optometry and ophthalmology consolidation, medical devices and medical technology/software companies.”
In addition to Preator’s Essilor and vision care industry experience, he has held several leadership positions during his 10 years within the hospitality field as well as various roles at PricewaterhouseCoopers within their advisory, audit and assurance, and transaction services groups.
Hull joined Kavanagh in November 2015, and his previous optical industry experience includes such roles as CFO at Nationwide Vision and at InteGreat Concepts.
Kavanagh Consulting operates three offices and has represented and provided advisory services to doctors and businesses within the vision care sector including labs, medical device firms, technology companies, retail organizations, optometry and ophthalmology practices, buying groups and new ventures/start-ups.